SCHEMBL6614937

SCHEMBL6614937

O=C1CCc2cc3c(cc2C1)OCO3

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
CYP2A6 P11509 1/20 0.43
CYP2D6 P10635 3/20 0.43
CHRNA7 P36544 1/20 0.42
ACHE P22303 1/20 0.41
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 4/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.37
GLA P06280 2/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
KMT2A Q03164 2/20 0.37
CMA1 P23946 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11332488 0.88 CYP2A6 (0.43) KDM4ECYP2A6CYP2D6ALDH1A1HSD17B10
SCHEMBL6582757 0.87 KDM4E (0.46) KDM4ECYP2D6CHRNA7ACHEALDH1A1
SCHEMBL5008100 0.79 CYP1A2 (0.51) KDM4ECYP2A6ALDH1A1MAPTHPGD
SCHEMBL16472556 0.77 CYP3A4 (0.44) KDM4ECYP2D6CHRNA7ACHEALDH1A1
SCHEMBL9739665 0.73 KDM4E (0.60) KDM4ECYP2D6CHRNA7ACHEALDH1A1
SCHEMBL8493767 0.73 CYP2A6 (0.50) CYP2A6ALDH1A1MEN1KMT2ACYP3A4
SCHEMBL1618660 0.72 CHRNA7 (0.50) KDM4ECYP2D6CHRNA7ALDH1A1HSD17B10
SCHEMBL10163669 0.72 CHRNA7 (0.50) KDM4ECYP2D6CHRNA7ACHEALDH1A1
SCHEMBL3267412 0.71 CYP2A6 (0.48) CYP2A6CYP3A4CYP1A2CYP2C9CYP11B1
SCHEMBL9343062 0.71 CYP2A6 (0.48) KDM4ECYP2A6ALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709526-B2 Use of cyclolignans and new cyclolignans BIOVITRUM AB (SE) 2010-05-04 US disclosed
US-7709526-B2 Use of cyclolignans and new cyclolignans BIOVITRUM AB (SE) 2010-05-04 US disclosed
EP-1042294-B1 HETEROCYCLIC CYTOTOXIC AGENTS UNIV RUTGERS (US) 2004-08-11 EP disclosed
US-6486167-B1 Heterocyclic cytotoxic agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-11-26 US disclosed
US-6140328-A FOR TREATING TUMOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-10-31 US disclosed
EP-1042294-A1 HETEROCYCLIC CYTOTOXIC AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-10-11 EP disclosed
WO-1999031067-A1 HETEROCYCLIC CYTOTOXIC AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-06-24 WO disclosed
US-4267178-A AS ANTIHYPERTENSIVE AGENTS SCIENCE UNION ET CIE, SOCIETE FRANCAISE DE RECHERCHE MED. (FR) 1981-05-12 US disclosed
US-4239903-A ANTISPASMODIC AGENTS DAIICHI SEIYAKU CO., LTD. (JP) 1980-12-16 US disclosed